Skip to main content
Clinical Trials/CTRI/2021/05/033782
CTRI/2021/05/033782Not yet recruitingPhase 3

Clinical study on Validation of Unani Pharmacopoeial formulation Habb e Qula in QulÄ? (Aphthous Ulcer)

Central Council for Research in Unani Medicine CCRUM New Delhi0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Subjects of either sex in the age group of 18-65 years
  • 2. Subjects with presence of single /multiple ulcers on the non-keratinized mucosa (labial, soft palate, buccal mucosa)
  • With and without any of the following symptoms
  • o Pain or burning sensation
  • o Excessive salivation
  • 2. Subjects with minor Aphthous Ulcers less than 1 cm in diameter

Exclusion Criteria

  • 1. Traumatic ulcers
  • 2. Disorders requiring long term treatment
  • 3. Known cases of underlying systemic diseases such as Crohnâ??s disease, ulcerative colitis, Celiac disease, lupus erythematosus, Behcetâ??s disease, Cyclic neutropenia, immunodeficiency disorders, lichen planus and malignancy
  • 4. Subjects with moderate to severe anemia
  • 5. Known allergy to any component of the test drug.
  • 6. Pregnant and lactating women.

Investigators

Sponsor
Central Council for Research in Unani Medicine CCRUM New Delhi

Similar Trials